Mycobacterium tuberculosis, the causative agent of human tuberculosis, is unique among bacterial pathogens in that it displays a wide array of complex lipids and lipoglycans on its cell surface. One of the more remarkable lipids is a sulfated glycolipid, termed sulfolipid-1 (SL-1), which is thought to mediate specific hostpathogen interactions during infection. However, a direct role for SL-1 in M. tuberculosis virulence has not been established. Here we show that MmpL8, a member of a large family of predicted lipid transporters in M. tuberculosis, is required for SL-1 production. The accumulation of an SL-1 precursor, termed SL 1278, in mmpL8 mutant cells indicates that MmpL8 is necessary for an intermediate step in the SL-1 biosynthesis pathway. We use a novel fractionation procedure to demonstrate that SL-1 is present on the cell surface, whereas SL 1278 is found exclusively in more internal layers. Importantly, we show that mmpL8 mutants are attenuated for growth in a mouse model of tuberculosis. However, SL-1 per se is not required for establishing infection as pks2 mutants, which are defective in an earlier step in SL-1 biosynthesis, have no obvious growth defect. Thus, we hypothesize that either MmpL8 transports molecules in addition to SL-1 that mediate host-pathogen interactions or the accumulation of SL 1278 in mmpL8 mutant cells interferes with other pathways required for growth during the early stages of infection.
M
ycobacterium tuberculosis is an intracellular pathogen that is highly adapted to infect and persist within mammalian tissues (1, 2) . Although little is known about the molecular mechanisms of M. tuberculosis virulence, an emerging paradigm is that cell wall lipids play important roles in the pathogenesis of this organism (3) . The cell wall of M. tuberculosis is a complex structure that is responsible for many of the unique properties of the organism (4) . One of the distinguishing features of the mycobacterial cell wall is the extremely long chain fatty acids, termed mycolic acids, which are esterified to the arabinogalactan core. In addition, a highly diverse set of surface-exposed lipids and glycolipids are noncovalently associated with the mycolic acids, creating an asymmetric bilayer structure (ref. 5 , see Fig. 6 ). Together, these features of the cell wall create a protective barrier that is vital for the survival of the organism within the host.
A rich literature exists that also implicates mycobacterial surface-exposed lipids in modulating specific host-pathogen interactions. Early work established a correlation between levels of two major cell wall lipids, sulfolipid-1 (SL-1, the most abundant sulfatide) and phthiocerol dimycocerosate (PDIM), and the virulence of M. tuberculosis (6, 7) . Indeed, purified SL-1, as well as other mycobacterial lipids such as trehalose 6,6Ј dimycolate and lipoarabinomannan, have interesting immunomodulatory activity when administered to animals or cultured immune cells (8) (9) (10) (11) (12) (13) (14) . PGL-1, a glycosylated version of PDIM found in Mycobacterium leprae, can suppress lymphocyte responses as well as facilitate Schwann cell invasion (15, 16) . Finally, the increased pathology of a M. tuberculosis clinical isolate has been attributed to differences in its surface-exposed lipids (17) .
Further evidence for the importance of surface-exposed lipids in the pathogenesis of M. tuberculosis came from two genetic screens that uncovered genes involved in lipid synthesis and secretion that are required for virulence (18, 19) . The ppsA-E and fadD28 genes are involved in synthesizing PDIM, and mutants lacking these genes exhibit a specific growth defect in the mouse lung. Although PDIM may be required for cell wall integrity (20) , the precise function of this molecule during infection is unknown. Interestingly, mmpL7 mutants fail to secrete PDIM and exhibit the same in vivo phenotype as PDIM-deficient mutants (18) (19) (20) .
MmpL7 is a member of a family of 13 predicted lipid transporters encoded by the M. tuberculosis genome. Many of these mmpL genes are adjacent to polyketide synthase genes in the chromosome, prompting the speculation that individual MmpL proteins transport the lipids produced by the neighboring synthases (21) . Indeed, this hypothesis is supported by the fact that mmpL7, ppsA-E, and fadD28 are clustered together in the genome. In this study, we describe the identification of another mmpL family member, mmpL8, and show that this gene, like the neighboring polyketide synthase pks2 (22) , is essential for SL-1 biosynthesis. Furthermore, we show that although SL-1 is dispensable during the acute stage of infection, mmpL8 is absolutely required for normal M. tuberculosis growth in vivo.
Materials and Methods
Media and Strains. M. tuberculosis cells (Erdman strain) were cultured as described (18) . For MS analysis, cultures were grown in a modified Sauton media (23) . The mmpL8::Tn5367-1, mmpL8::Tn5367-2, ⌬mmpL8, ⌬pks2, ⌬pks2 ϩ ppks2, and ⌬mmpL8 ϩ pmmpL8 strains are named jcm130, jcm131, jcm108, jcm119, scm6, and scm8, respectively. endogenous promoter and were created by subcloning from a cosmid, cERD4F2, into the integrating vector pMV306.kan.
Biochemical Analysis of PDIM and SL-1. Actively growing cultures were diluted to OD 600 ϭ 0.6 in a final volume of 50 ml. 14 C-propionate (7.5 Ci, 1 Ci ϭ 37 GBq) was added and incubation continued for 16 h at 37°C. Cell pellets were extracted essentially as described (18) . Lipids were separated on 10 cm ϫ 10 cm HPTLC plates (Alltech Associates) by using either hexanes͞ether (9:1) to resolve PDIM, or chloroform͞methanol͞ water (60:30:6) to resolve SL-1. Radioactive sulfate experiments were performed as above, except 100 Ci of 35 S-SO 4 2Ϫ was incubated with 10 ml of cells for 48 h.
For pulse-chase experiments, the cells were labeled for 30 min, pelleted, washed with media, and resuspended in 100 ml of radioactive-free 7H9 media. Ten-milliliter aliquots were removed at different time points and the cells were harvested for lipid extraction.
To analyze surface-exposed lipids from M. tuberculosis, 7.5 Ci of 14 C-propionate was added and incubated for 2 h to strongly label both SL-1 and SL 1278 . Cell pellets were resuspended in 1-ml hexanes͞0.05% decylamine and sonicated by using a Branson Sonifier 250 with a 2-in cup horn chamber (Branson) at 25% for 90 s. The supernatant and cell pellet were recovered by centrifugation, and decylamine was removed by extracting 3ϫ with 0.1 N HCl. Lipids were extracted and analyzed as described above.
MS. Lipid 2 from ⌬mmpL8 mutant cells was partially purified by using preparative TLC plates and eluted with CHCl 3 ͞MeOH (1:2). The recovered lipids were dried under nitrogen and dissolved in CHCl 3 ͞MeOH (2:1). Spectra were obtained by using a Bruker Apex II Fourier transform ion cyclotron resonance MS (Bruker, Billerica, MA) equipped with a 7T actively shielded magnet as described (23) . Spectra were acquired in the negative ion mode using electrospray ionization and were composed of 512,000 data points. Authentic SL-1 was obtained from Colorado State University (National Institutes of Health, National Institute of Allergy and Infectious Disease Contract N01 AI-75320).
Infection of Individual M. tuberculosis Mutants. Actively growing wild-type, jcm108, and jcm119 strains were washed, resuspended in 1ϫ PBS and 0.1% Tween, and sonicated. C57BL͞6 mice were infected by tail injection with 1-2 ϫ 10 6 colony-forming units (cfu) of each strain by using an OD 600 ϭ 3 ϫ 10 8 cfu⅐ml
Ϫ1
. Organs from infected mice were homogenized and plated as described (18) .
Results

Isolation of mmpL8 Transposon Mutants from a Screen for Attenuated
Strains. In an extension of a previous screen to identify genes involved in virulence of M. tuberculosis, we identified two mutants with transposon insertions in the same gene, mmpL8 (Fig. 1A) . Because each transposon contained a unique sequence tag, the representation of these mutants within pools of 48 random mutants could be quantified by amplification of all of the tags, followed by labeling and hybridization to filter arrays spotted with each individual tag. As shown in Fig. 1B , both of these mutants were equally represented in inoculum pools, yet markedly underrepresented after 3 weeks of growth in the lungs of infected mice. These results suggested that mmpL8 is required for growth during the early stages of infection (see below).
Inspection of the genomic location of mmpL8 revealed that it is near pks2, which encodes a polyketide synthase required for synthesizing phthioceranic and hydroxyphthioceranic acids, the methyl-branched acyl constituents of sulfolipid-1 (SL-1) (ref. 22 , Fig. 1 A) . To study mmpL8 and pks2, we removed the entire ORFs from a wild-type M. tuberculosis strain and confirmed these deletions by Southern blot (Fig. 1C) . Importantly, deletion of either gene did not affect growth in culture as the doubling time of ⌬mmpL8, ⌬pks2, and wild-type cells were 20. C-propionate, yet they are distinguishable by their mobility on TLC plates. As expected, SL-1, a major species in wild-type cells, is completely absent in extracts prepared from the ⌬pks2 mutants ( Fig. 2 A, lane 2) . Reintroduction of the pks2 gene restored the ability of the strain to synthesize SL-1 (lane 3). Interestingly, we noted a minor species (lipid 2) that was present in the complemented ⌬pks2 strain as well as the wild-type, but was absent in ⌬pks2 cells.
Like ⌬pks2 mutants, each of the mmpL8 transposon mutants and the ⌬mmpL8 strain failed to synthesize SL-1 ( Fig. 2 A, lanes Signature DNA tags from mutant mycobacteria harvested from the inoculum and the lungs of two mice after 3 weeks of growth were amplified, radiolabelled, and hybridized to tag array filters (18) . Tags from the two underrepresented mmpL8 mutants are shown next to control tags that did not vary throughout the experiment. (C) ⌬mmpL8 and ⌬pks2 strains were generated by specialized transduction, and Southern blot revealed the expected bands indicating the replacement of the genomic sequence with the hygromycin cassette. For details, see Materials and Methods. [4] [5] [6] . This surprising result was confirmed by MS, which demonstrated that SL-1 was absent in extracts from both ⌬mmpL8 and ⌬pks2 mutant cells (data not shown). In contrast to the ⌬pks2 mutant, however, mmpL8 mutants accumulated a lipid species that co-migrated with the lipid 2 species detected in wild-type cells. This defect was due specifically to disruption of mmpL8 as a single copy of the intact gene fully restored SL-1 synthesis (lane 7). Notably, PDIM synthesis was not perturbed in either mmpL8 or pks2 mutants, suggesting that these genes function specifically in SL-1 and lipid 2 biosynthesis.
Next, we sought to determine whether lipid 2 and SL-1 share common structural features (see Fig. 2C ). The observation that lipid 2 is labeled with 14 C-propionate suggests that, like SL-1, this lipid also contains methyl-branched fatty acids (Fig. 2 A) . To determine whether lipid 2 contains a sulfur atom, we labeled both wild-type and ⌬mmpL8 cells with 35 S-SO 4 2Ϫ and separated total lipids by TLC. As shown in Fig. 2B (lane 1) , SL-1 from wild-type cells is labeled strongly with 35 S-sulfur, and overexposure of the TLC revealed that lipid 2 also contains 35 S-sulfur (data not shown). Importantly, the lipid 2 that accumulates in ⌬mmpL8 cells also contains 35 S-sulfur (lane 2). As expected, ⌬pks2 cells lack both SL-1 and lipid 2 (lane 3). Taken together, these results confirm that lipid 2 shares significant structural features with SL-1.
Mass Spectrometric Analysis of a Novel Lipid in ⌬mmpL8 Mutant Cells.
To further characterize the structure of lipid 2, we sought to determine its mass by using FT-ICR MS. Spectra from partially purified lipid 2 were complex, and included numerous lipid-like molecules (data not shown). Lipids can be identified based on a characteristic 14 Da spacing, which reflects heterogeneity in the acyl chain lengths that vary by (CH 2 ) n units. To distinguish the peaks corresponding to lipid 2 from contaminants, we used a novel approach that combines 34 S heavy isotopic labeling with high-resolution MS, to identify sulfur-containing compounds from complex mixtures (23) . In short, sulfur-containing mole- 
2Ϫ . By using this method on partially purified lipid 2 from mmpL8 mutant cells, a group of lipoforms within the m͞z range of 1270-1450 shifted by 2 Da in the 34 S-labeled sample indicating the presence of a sulfur atom in the underlying structure ( Fig. 3  A and B) .
In an effort to assign an elemental composition to lipid 2, we performed exact mass measurements on the smallest lipoform (m͞z 1278, SL 1278 ). The measured mass of SL 1278 was determined to be m͞z 1,277.91 and is within 11 ppm of the exact mass of a partially acylated sulfated trehalose (Fig. 3C) . This structure is consistent with the previously elucidated structure of fully acylated sulfolipid-1 (Fig. 2C) . The exact position of the hydroxyphthioceranic acid could not be determined by this approach, but it is likely to be present on either the 6-or 6Ј-position of trehalose. SL 1278 was recently identified as a minor sulfated species found in M. tuberculosis (23) , consistent with our finding that SL 1278 is present in minor quantities in wild-type cells (Fig.  2 A, lane 1) .
Biochemical Analysis of Cell Wall Lipids in M. tuberculosis mmpL
Mutants. To determine whether SL 1278 is a true biosynthetic precursor of SL-1, we performed pulse-chase experiments. Wild-type and mmpL8 mutant cells were labeled briefly with 14 C-propionate, and total lipids were extracted at various time points and analyzed by TLC (Fig. 4A) . At early time points, both wild-type and ⌬mmpL8 mutant cells were capable of synthesizing significant amounts of SL 1278 . In wild-type cells, radiolabel appeared in SL-1 at later time points, whereas in mmpL8 mutant cells, radiolabeled SL 1278 persisted throughout the time course. Taken together these results strongly suggest that SL 1278 is a naturally occurring SL-1 precursor and that MmpL8 is required for SL-1 maturation.
Because MmpL8 is a member of a family of lipid transporters thought to export lipids from the cytoplasmic membrane to the cell wall of M. tuberculosis, we sought to determine the subcellular localization of SL-1 and SL 1278 . To this end, we developed a gentle fractionation procedure in which surface-exposed lipids were extracted from the outer leaflet of the cell wall, whereas lipids that reside in deeper layers remained cell associated. In brief, radioactively labeled cells were suspended in a mixture of mild organic solvents, gently sonicated, and centrifuged. Comparison of solvent-exposed lipids (supernatant, S) to the total lipid sample (pellet, P) allowed us to identify lipids present on the surface of the cell wall.
Previous work has demonstrated that PDIM is normally located on the cell surface in wild-type cells but present in the cytoplasmic membrane of mmpL7 mutant cells (18, 20) . Therefore, to validate our new procedure, we determined the subcellular localization of PDIM in both wild-type and mmpL7 mutant cells (Fig. 4B) . As expected, large amounts of PDIM were detected in the supernatant fraction from wild-type cells (Fig. 4B  Lower, lanes 1 and 2) . The presence of PDIM in the pellet fraction is likely a consequence of the gentle extraction procedure, resulting in incomplete extraction of surface-exposed lipids. Importantly, PDIM was found exclusively in the cell pellet fraction of mmpL7 mutant cells, in agreement with MmpL7's proposed function as a PDIM transporter (Fig. 4B Lower, lanes  3 and 4) . This result demonstrates the utility of this assay for probing the exterior portions of the cell wall for the presence of lipids.
Next, we sought to determine the subcellular localization of SL-1 and SL 1278 in wild-type and ⌬mmpL8 mutant cells. Based on our pulse-chase experiments, we labeled cells for 2 h to visualize both species by TLC. In wild-type cells, SL-1 is found in the supernatant fraction, demonstrating that this lipid is present on the cell surface, whereas SL 1278 is never detected on the cell surface (Fig. 4B, lanes 1 and 2) . Likewise, in ⌬mmpL8 cells, SL 1278 is found exclusively in the cell pellet fraction, suggesting that it resides within interior portions of the cell (Fig.  4B, lanes 5 and 6) . SL-1 secretion is fully restored in the mmpL8 complemented strain (Fig. 4B, lanes 7 and 8) . To ensure that SL 1278 is soluble in the extraction solvent, we performed harsher, lytic extraction procedures and found abundant levels of SL 1278 in the supernatant fractions from wild-type and ⌬mmpL8 mutant cells (data not shown). Importantly, PDIM secretion is normal in ⌬mmpL8 mutant cells, whereas SL-1 synthesis and secretion is normal in ⌬mmpL7 mutant cells, demonstrating that these two MmpL family members act on distinct lipid substrates.
Role of MmpL8 and SL-1 in M. tuberculosis Infection. The identification of mmpL8 from our transposon screen suggested that Fig. 4 . SL1278 is a biosynthetic precursor of SL-1 and is not exposed on the mycobacterial cell surface. (A) Wild-type (Upper) and ⌬mmpL8 mutant (Lower) cells were pulsed labeled with 14 C-propionate for 30 min, washed to remove unincorporated label, and grown in liquid media. At the times indicated during the chase, cells were harvested, and lipids were extracted and analyzed by TLC. The ⌬mmpL8 sample at t ϭ 60 is underloaded, not deficient in SL 1278. (B) Cells were labeled with 14 C-propionate for 2 h, and surfaceexposed lipids (S) were extracted by using hexanes͞decylamine and gentle sonication. Cell pellets (P) containing the lipids not extracted by this procedure were harvested by centrifugation and lipids from both fractions were extracted and analyzed by TLC. SL-1 is important for M. tuberculosis pathogenesis. To test this notion, we infected mice by the i.v. route with wild-type, ⌬pks2, and ⌬mmpL8 mutant strains and monitored their growth in vivo. Surprisingly, ⌬pks2 mutant cells grew at rates indistinguishable from that of wild-type cells in the spleen, liver, and lung, indicating that SL-1 is not necessary for M. tuberculosis growth during the innate phase of immunity (Fig. 5 A-C) . In marked contrast, ⌬mmpL8 mutant cells were attenuated in all of these organs. In the spleen and liver, ⌬mmpL8 mutant cells grew initially but, unlike wild-type cells, were rapidly eliminated after the 7-day time point. ⌬mmpL8 mutants also showed a subtle yet statistically significant growth defect in the lung that resulted in threefold fewer bacteria by 6 weeks after infection compared with wild-type cells (Fig. 5C ). Taken together, these results demonstrate that, although SL-1 is dispensable for M. tuberculosis replication during infection, MmpL8 is required for sustained bacterial growth and persistence.
Discussion
In this study, we identified mmpL8 in an unbiased screen for genes required for M. tuberculosis virulence. Using this same methodology, we had previously identified a homologous lipid transporter, mmpL7, which is required for PDIM secretion and M. tuberculosis virulence (18) . Surprisingly, mmpL8 mutants show a dramatic SL-1 synthesis defect, whereas mmpL7 mutants can fully synthesize PDIM and only fail to export it to the cell wall. Furthermore, we have shown that mmpL8 functions in a step downstream of pks2 in the SL-1 biosynthetic pathway, as a partially acylated precursor, termed SL 1278 , accumulated intracellularly in mmpL8 mutants. Using a powerful new technique to identify sulfated compounds, we were able to assign a molecular structure to this intermediate that is consistent with previous structural analysis of SL-1 (25, 26) . Finally, pulse-chase analysis revealed that this is a natural intermediate in wild-type cells, rather than an aberrant by-product of mmpL8 mutation.
These results have allowed us to draw a model of SL-1 biosynthesis and the role of mmpL8 in distal steps of this pathway (Fig. 6 ). Because pks2 mutants synthesize neither SL-1 nor SL 1278 , and because SL 1278 contains one hydroxyphthioceranic acid, it is likely that Pks2 works in a more proximal step in the pathway. Additional enzymes must also function upstream of MmpL8, as the trehalose head-group of SL 1278 has undergone sulfation and two acyltransferase reactions. The enzymes that catalyze these reactions and the order in which they function is unclear. Likely candidates for the sulfation step are one or more of the three sulfotransferases encoded by the M. tuberculosis genome (27) . It is also tempting to speculate that the other genes in the mmpL8 genomic region, papA1 or fadD23 (Fig. 1 A) , may encode the acyltranferases required for the assembly of SL-1.
Why might MmpL8, a predicted lipid transporter, be required for SL-1 biosynthesis? One possibility is that MmpL8, unlike MmpL7, may have some unknown catalytic activity and directly modifies SL-1 during its production. Perhaps more likely is that MmpL8 plays an indirect role in SL-1 biogenesis, consistent with its proposed lipid transport function. As shown in Fig. 6 , MmpL8 may flip SL 1278 across the plane of the cell membrane, allowing it to be further modified into mature SL-1 before delivery to the cell wall. The enzymes that catalyze these later steps are unknown.
Delivery of lipid intermediates to extracytoplasmic synthases may be a common feature among some members of the MmpL family and homologues in related bacterial species. For example, Mycobacterium smegmatis mutants deficient in TmtpC, a mmpL family member, are unable to synthesize glycopeptidolipid (28) . Likewise, when the mmpL homologue, actII-ORF3 is disrupted in Streptomyces coelicolor, actinorhodin synthesis is altered (29) . Thus, mmpL7 mutants may still synthesize mature PDIM because the entire synthesis machinery is localized to the cytoplasmic side of the cell membrane.
In addition to MmpL8's role in SL-1 biosynthesis, we have also shown that MmpL8 is required to establish a high-level infection in mice. We initially isolated mmpL8 mutants based on their competitiveness in a pooled infection and subsequently demonstrated that these mutants are defective for growth in all organs tested when infected as a clonal population. Interestingly, pks2 mutants, which are also defective for SL-1 biosynthesis, are not attenuated during mouse infection. Thus, despite previous evidence implicating SL-1 in pathogenesis, our results clearly demonstrate that SL-1 per se is not required for growth of M. tuberculosis during the acute phase of infection in mice. We cannot rule out that SL-1 may be required during chronic infection of mice or perhaps plays a role in human M. tuberculosis infection that is not apparent in the mouse model of tuberculosis. However, the clear defect of mmpL8 mutants suggests that other MmpL8-dependent processes, besides SL-1 synthesis, are important for M. tuberculosis to thrive during innate immune responses.
There are several models that could explain the paradoxical in vivo growth of pks2 and mmpL8 mutants. The simplest model is that MmpL8 may transport other substrates in addition to SL-1, and it is these molecules that are important for pathogenesis.
Although we have no direct evidence that argues against this model, using numerous experimental approaches we have not identified additional lipids whose synthesis or secretion is blocked in mmpL8 mutants. A second model is that the accumulation of SL 1278 may be generally toxic to the mmpL8 mutant cells. However, this effect would have to be manifest only during infection, as mmpL8 mutants grow with wild-type kinetics in liquid culture. Alternatively, the accumulation of SL 1278 in mmpL8 mutant cells may cause a specific inhibition of other pathways required to avert host defenses. For example, the accumulation of the sulfated lipid may inhibit a sulfotransferase, leading to a perturbation in sulfate homeostasis and, as a result, an alteration of host-pathogen interactions. Whether any of these or perhaps other models can explain the phenotypic differences between mmpL8 and pks2 mutants remains unknown.
MmpL8 is the second member of the MmpL lipid tranporter family demonstrated to be required for virulence. It is likely that other members of this family of transporters perform critical functions during M. tuberculosis virulence. Whether the lipids transported by MmpL proteins play only a structural role in the cell wall or perhaps mediate specific host-pathogen interactions remains to be elucidated. In either case, the MmpL family is an attractive target for the design for new antituberculosis drugs.
